Navigation Links
John Theurer Cancer Center experts present new cancer research at ASCO Annual Meeting
Date:6/4/2010

HACKENSACK, N.J. (June 3, 2010) The John Theurer Cancer Center at Hackensack University Medical Center announced today important research findings that will be presented at the American Society of Clinical Oncology (ASCO) annual meeting taking place June 4 8, 2010 in Chicago. Research highlights include a comparison of first-line treatments for an aggressive form of lymphoma, the efficacy and safety of a new genetically engineered cancer therapy, and the value of a commonly used tool for staging lymphoma. These findings are only three of 16 studies that will be discussed by researchers from the John Theurer Cancer Center.

"We are excited to present significant research findings, particularly in the area of hematological malignancies, as part of our continued commitment to advance cancer research," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chairman and Executive Administrative Director, John Theurer Cancer Center. "The studies we will present at ASCO represent just a small sample of the work that we do to improve outcomes not just for our patients, but for the cancer community as a whole."

Research to be presented at ASCO by researchers at the John Theurer Cancer Center will showcase treatment advancements for cancers of the blood, including lymphoma and multiple myeloma. Poster presentation highlights in these areas include:

Rituximab, fludarabine, mitoxantrone, and dexamethasone (R-FND) combination may help patients with relapsed indolent B-cell lymphoma. (Abstract number 8078; poster session, June 5, 8:00 a.m. 12:00 p.m.)

Andre Goy, M.D., Deputy Director and Chief, Lymphoma at the John Theurer Cancer Center collaborated with researchers at other major cancer centers to examine the value of adding rituximab to FND (fludarabine, mitoxantrone, and dexamethasone) combination therapy for relapsed indolent B-cell lymphoma. While rituximab is often used as a treatment option for patients with this condition, o
'/>"/>

Contact: Amy Leahing
amy.leahing@widmeyer.com
646-213-7245
John Theurer Cancer Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Leading physicians and researchers at the John Theurer Cancer Center present research at ASCO
2. John Theurer Cancer Center offers breakthrough radiation measurement technology
3. John Theurer Cancer Center hosts hematologic malignancies program for physicians and patients
4. Researchers at the John Theurer Cancer Center Present Cutting-Edge Research Results at this Years American Society of Hematology Annual Meeting
5. AACR Adds to Growing STAR P-2 trial; Publishes Update and Perspectives in Cancer Prevention Research
6. Stage II and stage III colon cancer patients treated after 1995 have improved overall survival
7. Cysts hold clues to pancreatic cancer
8. Interruption of Menstrual Cycle by Chemotherapy Associated with Improved Survival in Early Breast Cancer
9. Olive-oil enriched diet helps breast cancer survivors lose more weight
10. Longer Drug Regimen Still Best Against Breast Cancer
11. Sun-induced skin cancer: new discovery permits doctors to assess genetic risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Texas Physical Therapy Specialists (TexPTS) is proud to ... Liberty Hill, Parmer, Balcones, and Georgetown clinics have received ... Certified Specialist (OCS) or Sports Certified Specialist ... Tony Lauretta, PT, DPT, OCS, Jason Brown, PT, DPT, ... DPT, OCS, and Mary Grimberg, PT, DPT, OCS received ...
(Date:7/23/2014)... the likelihood of forming false memories, according to research ... the Association for Psychological Science. , In a study ... University of California, Irvine and colleagues, sleep-deprived people who ... read false information about the photos were more likely ... than were those who got a full night,s sleep. ...
(Date:7/23/2014)... CarePoint Health is proud to announce ... Jersey to receive the da Vinci® Xi™ Surgical System, ... da Vinci series. This 4th generation robotic platform is ... innovation. The intuitive da Vinci Xi has broad capabilities ... minimally invasive and complex surgical procedures. The acquisition of ...
(Date:7/23/2014)... The North American market was valued at $985.4 million ... CAGR of 10.79%, to reach $1,801.1 million by 2018. Organobromines ... North American Bromine Market report defines and segments the bromine ... Browse through the TOC of the North American Bromine Market ... This also provides a glimpse of the segmentation in the ...
(Date:7/23/2014)... Recently, Agebc.com has launched its new ... is announcing a promotion of wedding dresses. According to ... at the end of this month. , The beautiful ... like A-line, mermaid, ball-gown, empire, and more. Agebc.com is ... special-occasion dresses for women, and the company is devoted ...
Breaking Medicine News(10 mins):Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 2Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 3Health News:Sleep deprivation may increase susceptibility to false memories 2Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 2Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 3Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 4Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 4Health News:Agebc.com Launched Its New Collection of Wedding Dresses 2
... Bird, a molecular geneticist at the University of Edinburgh, Scotland, ... of a protein called Uqcrc1 in the brains of mouse ... which are the powerhouses of the cells to work overtime. ... mitochondrial gene has been linked to Rett Syndrome. The co-author ...
... that the male survivors of childhood sexual abuse ... understood// many health care practitioners as well as ... male and female childhood sexual survivors usually exhibit ... encounters with health care professionals, there are gender ...
... that New Orleans seems to be going throuogh a ... intensity rarely seen in the US. ,Suicide ... struck, 10 months ago. To make matters worse the ... the police department to deal with the large number ...
... University and the Celiac Sprue Research Foundation have claimed ... celiac sprue// that is an inherited inflammatory disorder of ... around the world. The two research studies that have ... Biology have opened the way for clinical testing with ...
... Cadbury Ireland had on the 23rd June recalled almost ... move because there are fears// that those bars may ... the company has said that there were minute traces ... levels that stipulated by the scientific standards for any ...
... to use a protein that has been originally isolated from ... genetically// modified technology. ,The parent company, Unilever, have ... ice creams that are of low-calorie, and low fat. They ... newer versions of their best selling products like the Cornetto, ...
Cached Medicine News:Health News:Researchers Have Linked Rett Syndrome to Mitochondrial Gene 2Health News:Researchers Have Linked Rett Syndrome to Mitochondrial Gene 3Health News:Sexually Abused Males Found Struggling In heir relations with Healthcare Providers 2Health News:Scientists Discover Non-dietary Therapy For Celiac Diseases 2Health News:Wall's To Develop Low-fat Ice-cream Using Fish Blood 2
(Date:7/23/2014)... Pa. , July 23, 2014 /PRNewswire/ ... today announced successful results from its randomized, ... in women with biopsy-proven cervical intraepithelial neoplasia ... types 16 or 18. Treatment with VGX-3100, ... of CIN2/3 to CIN1 or no disease, ...
(Date:7/23/2014)... , July 23, 2014  Nearly 8,000 attendees will ... Cardinal Health,s annual Retail Business Conference (RBC), taking place ... Center. This year,s event encourages pharmacists to "Lead Change" ... communities and for their future. ... to network with their peers and learn new ways ...
(Date:7/23/2014)... 23, 2014  Mevesi Inc. would like to ... integration provides pharmacies with the ability to send ... patients. Mevesi,s solutions provide an ... to define target marketing campaigns. This coupled with ... within the Digital Marketing, Population Management, and Pharmacy ...
Breaking Medicine Technology:Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 6Mevesi Enhances Solutions with Variable Print Media Capabilities! 2
... LOUIS, Jan. 11, 2011 Stereotaxis, Inc. (Nasdaq: ... procedure with the Vdrive™ robotic navigation system as the ...   In the first procedure with the ... of Clinical Electrophysiology at the Erasmus Medical Center in ...
... Mich., Jan. 10, 2011 Stryker Corporation (NYSE: ... for the fourth quarter of 2010, representing an 8.8% increase ... of 2009, and were $7,320 million for the year ended ... of $6,723 million for the year ended December 31, 2009. ...
Cached Medicine Technology:Stereotaxis Announces CE Mark and First Human Case for Vdrive™ 2Stereotaxis Announces CE Mark and First Human Case for Vdrive™ 3Stryker Increases Expected 2010 Results and Provides 2011 Outlook 2Stryker Increases Expected 2010 Results and Provides 2011 Outlook 3Stryker Increases Expected 2010 Results and Provides 2011 Outlook 4Stryker Increases Expected 2010 Results and Provides 2011 Outlook 5Stryker Increases Expected 2010 Results and Provides 2011 Outlook 6Stryker Increases Expected 2010 Results and Provides 2011 Outlook 7
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: